Skip to content

The application of Bu-Shen-Ning-Xin decoction combined with dehydroepiandrosterone therapy in postmenopausal osteoporosis

The application of Bu-Shen-Ning-Xin decoction combined with dehydroepiandrosterone therapy in postmenopausal osteoporosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005743
Enrollment
Unknown
Registered
2021-07-12
Start date
2015-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postmenopausal osteoporosis

Interventions

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Subjects volunteer to participate in this study and sign the informed consent; 2. Aged 45 to 78 years old; 3. Postmenopausal women; 4. There is no obvious abnormality in physical examination and laboratory results except for osteoporosis related indexes; 5. Subjects meet the diagnostic criteria.

Exclusion criteria

Exclusion criteria: 1. Subjects with second osteoporosis or serious complications; 2. Ongoing use of any drugs which can affect bone metabolism; 3. Fresh fracture, late deformity, or disability; 4. Subjects with a history of severe multiple fractures; 5. Contraindications to hormone replacement therapy; 6. Subjects who had experienced cardiovascular and cerebrovascular diseases, hepatic disease, renal disease, lung diseases, hemopoietic system diseases or psychopath.

Design outcomes

Primary

MeasureTime frame
liver function;renal function;bone mineral density;

Countries

China

Contacts

Public ContactWang Ling

Obstetrics and Gynecology Hospital of Fudan University

dr.wangling@fudan.edu.cn+86 18221815182

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026